Remove 2022 Remove Healthcare Innovation Remove Leadership Remove Life Science
article thumbnail

Scotland's Pioneering Spirit: A Legacy of Medical and Healthcare Innovation

Lloyd Price

As the digital health sector continues to grow, Scotland is well-positioned to play a leading role in shaping the future of healthcare. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

article thumbnail

Healthcare Innovation Funding – Current Factors to be Aware of and Navigating Long Buying Cycles

Healthcare IT Today

To get you the best advice, we reached out to our brilliant Healthcare IT Today Community to share their insights on these two points. Dan Martin, Executive Vice President, Healthcare at PAN Communications Digital health and HIT funding has shifted significantly in the last couple of years. The following is what they had to share.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Authenticx Announces $20M in Series B Funding to Enhance the Customer Journey

Healthcare IT Today

Authenticx , the new standard in healthcare for listening to customer voices at scale, today announced $20M in Series B funding led by Blue Heron Capital with participation from Beringea, Indiana Next Level Fund/50 South Capital Advisors, High Alpha, Mutual Capital Partners, Signal Peak Ventures, Allos Ventures, Elevate Ventures and M25.

article thumbnail

Corporate Venture Capital's growing role and importance in HealthTech

Lloyd Price

Examples of Corporate Venture Capital in Healthtech Numerous notable examples highlight the active involvement of CVC in the healthtech sector: Johnson & Johnson Innovation: Through its CVC arm, Johnson & Johnson has invested in over 200 healthtech startups, focusing on areas such as digital health, medical devices, and biotechnology.

article thumbnail

Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure

Digital Health Global

Combines Miromatrix’s expertise in bioengineered organs with Baxter’s leadership in critical care delivery and organ support therapies Includes intended Phase I clinical trial designed to generate key evidence to support additional therapeutic options for patients suffering from acute liver failure EDEN PRAIRIE, Minn. &

article thumbnail

Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion

Digital Health Global

Advent International and Warburg Pincus have extensive experience helping innovative healthcare companies advance their mission and strategic priorities. This investment underscores our commitment to working with companies that support the delivery of innovative life sciences products and services worldwide.” “BPS